How promotion of prescription medicines differs across jurisdictions
Laws, guidance, industry codes, litigation against pharmaceutical companies, case law and legal commentary for Japan, the US, Canada, the EU, Switzerland, the UK, Russia, Australia, China and Korea, each linked to its source. Once a week Jev (an AI that makes language judgements) searches for new material, judges relevance and type, and updates the pages. Each jurisdiction's basics show only statements with a source and a check date; anything not yet researched is marked as such.
10 jurisdictions × 6 types (number of items)
| Jurisdiction | Basics (verified) | Laws & regulations | Notices & guidance | Industry codes & rules | Litigation | Case law | Legal commentary |
|---|---|---|---|---|---|---|---|
| Japan | 8/8 | 3 | 1 | 3 | 1 | 0 | 0 |
| United States | 8/8 | 23 | 166 | 3 | 120 | 27 | 27 |
| Canada | 8/8 | 7 | 0 | 3 | 1 | 2 | 1 |
| European Union | 8/8 | 4 | 1 | 10 | 0 | 6 | 2 |
| Switzerland | 8/8 | 2 | 1 | 1 | 0 | 0 | 0 |
| United Kingdom | 8/8 | 1 | 2 | 35 | 3 | 0 | 0 |
| Russia | 0/8 | 3 | 0 | 0 | 1 | 0 | 0 |
| Australia | 8/8 | 3 | 2 | 1 | 1 | 0 | 0 |
| China | 8/8 | 1 | 0 | 0 | 2 | 0 | 1 |
| Korea | 8/8 | 1 | 4 | 0 | 5 | 0 | 1 |
Latest records (from 1990 onward, newest first)
- KoreaNotices & guidance2026-10-02foodtoday.or.kr[2026 국감] ‘선 넘은 의약품 광고’ 5년간 32건…반복 위반에 허가취소도
- KoreaNotices & guidance2026-09-29데일리팜Intensive inspection of poorly packaged and labeled medicines, illegal advertisements for obesity, etc.포장·표시 불량 의약품, 비만약 불법 광고 등 집중 점검
- KoreaLitigation2026-09-28hitnews.co.krJW Pharma Wins KFTC ‘Academic Marketing’ Case
- United StatesLitigation2026-09-26Lawsuit Information CenterGabapentin Dementia Lawsuit
- United KingdomIndustry codes & rules2026-09-25Fierce PharmaEli Lilly blasted for ‘promotional and emotive’ language in GLP-1 press release
- United KingdomIndustry codes & rules2026-09-25Fierce PharmaGSK slammed for ‘grossly misleading’ and ‘totally unacceptable’ behavior
- ChinaLitigation2026-09-22光明网Accepted 46 bribes in 11 years, with a total amount of 184 million yuan involved. A hospital in Hebei has been "hunted" by more than 30 pharmaceutical companies for a long time11年受贿46次 涉案金额累计1.84亿元 河北一医院被30多家药企长期“围猎”
- United StatesLitigation2026-09-21Latham & Watkins LLPDompe Settlement Highlights DOJ Continued Scrutiny of Pharmaceutical Manufacturer Donations
- KoreaLitigation2026-09-21news.sbs.co.krShock Lawsuit Over Vision Loss After Taking Wegovy... "Foreign Countries Already Issued Warnings," What About Korea?
- KoreaLitigation2026-09-18여성소비자신문Kwangdong Pharmaceutical and GC Cell initiate legal action for illegal comparative advertising... Obtained approval for use for therapeutic purposes at GCC 2005광동제약·지씨셀, 불법 비교광고 행위 법적 조치 착수...GCC2005 치료목적 사용승인 획득
- ChinaLitigation2026-09-13珠海网The National Medical Insurance Administration announced a commercial bribery case involving medical institutions in the purchase and sale of medicines国家医保局公布医疗机构涉医药购销商业贿赂案
- United StatesLitigation2026-09-11RegtechtimesDompé u.s. agrees to pay $32m to resolve false claims act liability relating to self-disclosure of patient kickbacks — DOJ
- United StatesLitigation2026-09-10Washington TimesDompe to pay $32 million over Medicare co-pay scheme for eye drug
- KoreaNotices & guidance2026-09-03Korea Biomedical ReviewKorea tightens growth hormone oversight as industry pushes back on ‘misuse’ label
- AustraliaLitigation2026-09-02AFRNovartis lawsuit accuses Australian boss of double-dealing with Bastas
- RussiaLaws & regulations2026-08-31Medicine and lawPrescription Medicine Advertising in Russia: A Quest for Ethical Regulation
- RussiaLaws & regulations2026-08-31Medicine and lawPrescription Medicine Advertising in Russia: A Quest for Ethical Regulation
- United StatesLitigation2026-08-26JDSupraCooperation, Compliance, and Consequences: Inside DOJ's $46 Million Veloxis Settlement